Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Levitzki

Showing results (201-210 of 244) with videos related to

Pageof 25
Sort By:
Anti-Cancer Drugs|April 1, 1994
Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemiaG Kaur, A Gazit, A Levitzki, et al.
The Journal of Clinical Investigation|August 1, 1997
Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascitesJ C López-Talavera, A Levitzki, M Martínez, et al.
Biochemical Society Symposium|January 1, 1986
The hormonal regulation of adenylate cyclaseD Feder, M J Im, T Pfeuffer, et al.
Bioorganic & Medicinal Chemistry|August 1, 1996
Tyrphostins IV--highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolinesA Gazit, J Chen, H App, et al.
Biochemistry|May 27, 1997
Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296M Kovalenko, L Rönnstrand, C H Heldin, et al.
Oncogene|September 15, 2015
Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signalingE Sanchez-Lopez, E Flashner-Abramson, S Shalapour, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 2001
High-performance liquid chromatographic analysis of the tyrphostin AG1478, a specific inhibitor of the epidermal growth factor receptor tyrosine kinase, in mouse plasmaA G Ellis, E C Nice, J Weinstock, et al.
Biochemical Pharmacology|September 1, 1992
Inhibition of platelet activation by tyrosine kinase inhibitorsF Rendu, A Eldor, F Grelac, et al.
The Journal of Biological Chemistry|November 5, 1991
Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogueC Y Hsu, P E Persons, A P Spada, et al.
Experimental Dermatology|April 1, 1995
Tyrphostins suppress the growth of psoriatic keratinocytesH Ben-Bassat, D V Vardi, A Gazit, et al.
Pageof 25

Showing results (201-210 of 244) with videos related to

Sort By:
Pageof 25
Anti-Cancer Drugs|April 1, 1994
Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemiaG Kaur, A Gazit, A Levitzki, et al.
The Journal of Clinical Investigation|August 1, 1997
Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascitesJ C López-Talavera, A Levitzki, M Martínez, et al.
Biochemical Society Symposium|January 1, 1986
The hormonal regulation of adenylate cyclaseD Feder, M J Im, T Pfeuffer, et al.
Bioorganic & Medicinal Chemistry|August 1, 1996
Tyrphostins IV--highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolinesA Gazit, J Chen, H App, et al.
Biochemistry|May 27, 1997
Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296M Kovalenko, L Rönnstrand, C H Heldin, et al.
Oncogene|September 15, 2015
Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signalingE Sanchez-Lopez, E Flashner-Abramson, S Shalapour, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 2001
High-performance liquid chromatographic analysis of the tyrphostin AG1478, a specific inhibitor of the epidermal growth factor receptor tyrosine kinase, in mouse plasmaA G Ellis, E C Nice, J Weinstock, et al.
Biochemical Pharmacology|September 1, 1992
Inhibition of platelet activation by tyrosine kinase inhibitorsF Rendu, A Eldor, F Grelac, et al.
The Journal of Biological Chemistry|November 5, 1991
Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogueC Y Hsu, P E Persons, A P Spada, et al.
Experimental Dermatology|April 1, 1995
Tyrphostins suppress the growth of psoriatic keratinocytesH Ben-Bassat, D V Vardi, A Gazit, et al.
Pageof 25